Back to Results

InfuSystems Holdings Inc (INFU)

Featured in High-Momentum Stocks

InfuSystems Holdings Inc (INFU) is a common stock listed on the NYSE in the healthcare sector, within healthcare providers and services. The security reflects an equity interest in InfuSystems Holdings Inc, a company associated with infusion-related equipment and support services. Its business context includes rental and sale of infusion pumps, related disposable supplies, and maintenance or repair work for clinical and home-based care settings. The company also serves healthcare providers that use infusion therapy equipment across different treatment environments. This overview describes the listed common equity and the operating areas tied to the company’s healthcare services activity.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-INFU
$16.54
26.2% Upside
Undervalued
$16.83
28.4% Upside
Undervalued
Great
0.0%
November 10, 2026
30.6x
4.4x
1.8x
261.1 M
284.7 M
8.6%
94.1%
5.5
146.9%
Valuation • Fair Value

InfuSystems Holdings Inc (NYSE-INFU) Fair Value by Valuation Model

Review the available estimates for InfuSystems Holdings Inc (NYSE-INFU), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$16.54

Estimated upside of 26.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$20.11

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.76

Classic Ben Graham valuation formula reference.

Comps Fair Value

$12.97

Comparable-company valuation reference.

Analyst Price Target

$16.83

Analysts imply upside of 28.4%.

How to read these valuation models

Use the 6 available valuation references for InfuSystems Holdings Inc (NYSE-INFU) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for InfuSystems Holdings Inc (NYSE-INFU)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

143.3 M

Current operating scale indicator.

Revenue Forecast

145.3 M

Forward revenue estimate.

EBITDA

24.229 M

Current operating profitability reference.

EBITDA Forecast

32.15 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review InfuSystems Holdings Inc (NYSE-INFU) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for InfuSystems Holdings Inc (NYSE-INFU)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

9

Relatively strong quality score.

Beneish M-Score

-3.11

No elevated caution signal from this screen.

Altman Z-Score

5.5

Relatively strong balance-sheet zone.

FCF / Net Income

146.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for InfuSystems Holdings Inc (NYSE-INFU). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for InfuSystems Holdings Inc (NYSE-INFU)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for InfuSystems Holdings Inc (NYSE-INFU), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

InfuSystems Holdings Inc (NYSE-INFU) Stock Forecast & Technical Outlook

Review InfuSystems Holdings Inc (NYSE-INFU) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for InfuSystems Holdings Inc (NYSE-INFU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for InfuSystems Holdings Inc (NYSE-INFU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for InfuSystems Holdings Inc (NYSE-INFU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for InfuSystems Holdings Inc (NYSE-INFU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for InfuSystems Holdings Inc (NYSE-INFU) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for InfuSystems Holdings Inc (NYSE-INFU)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, InfuSystems Holdings Inc (NYSE-INFU) has a Strong Buy consensus, with 3 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 3
Hold 0
Sell 0
FAQ • Fast Investor Answers

InfuSystems Holdings Inc (NYSE-INFU) Stock FAQ

Data-supported answers about InfuSystems Holdings Inc (NYSE-INFU), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$16.54
Estimated upside 26.2%
Valuation Rating
Undervalued
Estimated upside of 26.2%
Analyst Target
$16.83
Implied upside 28.4%
Financial Health
Great
Current financial-health read

The current fair value estimate for InfuSystems Holdings Inc (NYSE-INFU) is $16.54. This implies an estimated upside of 26.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 26.2% versus the current market price.

The available analyst price target for InfuSystems Holdings Inc (NYSE-INFU) is $16.83. The analyst target implies estimated upside of 28.4%.

The current financial health read for InfuSystems Holdings Inc (NYSE-INFU) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for InfuSystems Holdings Inc (NYSE-INFU) is November 10, 2026.

The latest available data indicates no current dividend yield for InfuSystems Holdings Inc (NYSE-INFU).

The current P/E ratio listed for InfuSystems Holdings Inc (NYSE-INFU) is 30.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for InfuSystems Holdings Inc is 261.1 M.

The current enterprise value listed for InfuSystems Holdings Inc is 284.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for InfuSystems Holdings Inc is NYSE-INFU, and the stock is listed on NYSE.

InfuSystems Holdings Inc (NYSE-INFU) is listed on NYSE.

The current debt-to-total-capital ratio listed for InfuSystems Holdings Inc is 8.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for InfuSystems Holdings Inc is 94.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B